Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adverse Events
Biotech
Abivax stock rebounds on colitis prospect safety data
Abivax has recovered from a dent in its share price after unveiling fresh safety data that appeared to ease investors' concerns.
James Waldron
Jun 30, 2026 10:27am
ADA: Tolerability questions linger for Boehringer's obesity drug
Jun 8, 2026 4:30am
ADA: Roche, Zealand make tolerability case for petrelintide
Jun 7, 2026 3:00am
Aardvark halts obesity trials, putting entire pipeline on pause
Mar 24, 2026 4:00am
Kalaris pauses eye drug trial to resolve ocular inflammation
Mar 11, 2026 6:30am
Aardvark pauses ph. 3 hunger trial over 'cardiac observations'
Mar 2, 2026 4:40am
